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Abstract 
In the current work, two groups of chlorhexidine mucoadhesive buccal tablets were 
prepared, using either rod or irregularly-shaped spherical particles of hydroxypropyl 
methylcellulose and different ratios of poloxamer 407 (P407). The tablets were 
designed to release the drug over two hours. Their physicochemical properties and 
drug release profiles were investigated. The impact on dry granulation, the ex-vivo 
mucoadhesion, the swelling index, the morphology of swollen tablets and the drug 
release kinetic were investigated. Drug-polymers chemical interaction was studied 
using Fourier Transforms Infrared Spectroscopy (FTIR) and differential scanning 
calorimetry (DSC). Due to different particle shapes, the preparation of dry granules 
required a 40 KN force for rod-shaped particles compared to 10 KN for the 
irregularly-shaped spherical particles. All formulations showed at least two-hours 
residence time using ex-vivo mucoadhesion. Statistically, there was no significant 
difference in the swelling index, drug release nor its kinetic for both groups. 
However, the microscopical morphology of the swollen tablet and the size of the 
pores were affected by particle shape. Increasing the ratio of P407 to 62.5% resulted 
in a pronounced increase in drug release from around 60% to >90% after two hours. 
Following the FTIR and DSC analyses, no chemical interaction was noted apart from 
the steric hindrance effect of P407, which was observed even with the physical 
mixtures. 
1 Introduction 
Hydroxypropyl methylcellulose (HM) has widely been used in the preparation of 
hydrophilic controlled release matrices due to its water solubility, pH stability and 
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resistance to enzymatic degradation, ease of manufacturing and low cost. It gels and 
swells upon contact with water forming a gelatinous layer that controls drug release 
(Ghori and Conway, 2015; Maderuelo et al., 2011).  Due to its mucoadhesive and 
hydrogel-forming properties, it has been investigated in buccal drug delivery and is 
included in marketed products (Sudhakar et al., 2006). There are several factors 
which affect drug release from HM matrices, for instance, particle size (Wan et al., 
2001), force of compression  (Velasco et al., 1999), molecular weight (Gao et al., 
1996), viscosity (Campos-Aldrete, 1997), drug polymer ratio (Velasco et al., 1999), 
and the incorporation of other polymers or excipients (Xie et al., 2017). There have 
been only a limited number of investigations which have highlighted the effect of 
particle shape on tablet swelling and drug release. For instance, Gustafsson et al., 
(1999) assumed that fibrous or rod-shaped HM particles have a lower hydration rate 
compared to irregular particles, which results in a lower gelling rate and 
consequently decreases the rate of drug release. Moreover, the morphology of the 
powder affects its flow properties and compactability. Rod-shaped interlocked upon 
compaction and produced higher tensile strength tablets, which consequently 
resulted in a decreased drug release rate (Gustafsson et al., 2003). Li et al. (2005)  
found that the rod-shaped particles in Methocel powder also interlocked, producing a 
stronger matrix which affected tablet swelling and decreased the rate of drug 
release.  
Poloxamer 407 (P407) or Pluronic F127 is a non-ionic surfactant polymer and has a 
thermo-reversible hydrogel-forming ability with a mucoadhesive property. It gels at a 
concentration of > 20% at 25°C (Ruel-Gariépy and Leroux, 2004). It is a copolymer 
of polyethylene oxide and polypropylene oxide, with the hydrophilic nature of the 
former and the hydrophobic nature of the latter resulting in an amphiphilic molecule 
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with consequent surfactant properties (Kabanov et al., 2002). It has a wide 
application in drug delivery, for example, in parenteral, ophthalmic, inhaler, oral 
solution, suspension, and topical formulations (Dumortier et al., 2006). In the current 
work, P407 was chosen due to its pronounced gelling properties and high viscosity 
of 3100 cP which is attributed to its high molecular weight compared to other 
poloxamers and its availability as microprills (Matanovi et al., 2014). Although, it is 
not commonly used in controlling the release of the drug from solid dosage forms, in 
the current work it was formulated in tablet dosage form to control the release of 
chlorhexidine (CHD) together with HM by exploiting its thermo-reversible hydrogel-
forming properties which promotes tablet wetting as a result of its surfactant 
property. 
CHD is cationic at physiologic pH, its bactericidal and fungicidal activity results from 
its ability to bind to phosphate-containing proteins in the bacterial or fungal cell walls 
and membranes which leads to structural disruptions and leakage of cytoplasmic 
components (Lim and Kam, 2008). The main advantage of oral formulations of CHD 
is their lack of a specific cellular target for microbiocidal activity which results in the 
retardation of the development of resistance against CHD (Ankola et al., 2008). CHD 
mouthwashes are prescribed as adjuvant for the treatment of oropharyngeal 
candidiasis (OPC) (Pereiro Ferreirós et al., 2012). The greatest disadvantage of 
current CHD formulations is their short retention and activity time in the oral cavity. 
Consequently, there is a real need for a new approach to the localised, prolonged 
delivery of antifungal agents for enhanced OPC therapy. The advantages of this 
mode of drug delivery are that it reduces the systemic side effects of the drug, 
minimizes the dose of the drug required and provides targeted drug delivery (Sankar 
et al., 2011). 
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In the present study, the impact of HM particle shape and/or the ratio of P407 on the 
properties and the release of CHD from mucoadhesive matrices are investigated. To 
the best of our knowledge, there has been no previous investigation into the impact 
of the shape of HM particles on tablet behaviour and release profile, after being dry 
granulated. The effects on the physicochemical properties of CHD matrix tablets for 
local oral drug delivery of HM rod and irregularly-shaped spherical particles were 
studied.  The tablets were designed to control the release for two hours which might 
not be achieved by HM. Accordingly, P407 was added to increase the hydrophilicity 
and maintain the hydrogel network structure. The effect of P407 on tablet behaviour 
and the CHD release profile was investigated.  
2 Materials and method 
2.1 Materials 
MethocelTM F4M premium hydroxypropyl methylcellulose (Methocel, viscosity of 
2663-4970 cps for 2% solution at  20°C, 27-30% methoxyl and 4-7.5% hydroxypropyl 
substitution) was kindly donated by the Dow-Colorcon Company in the U.K. 
Hydroxypropyl methylcellulose (HPMC, Mn ~86,000, viscosity of 4000 cps for 2% 
solution at  20°C, 29% methoxyl and 7% hydroxypropyl substitution), poloxamer 407 
(P407) and chlorhexidine diacetate salt hydrate (CHD) were purchased from Sigma 
Aldrich in the UK and Magnesium stearate from Alfa Aesar, also in the UK. 
2.2 Solubility of CHD  
The solubility of CHD was investigated in ultra-pure water and a phosphate buffer 
saline (PBS) solution pH 6.8, as a simulated salivary pH to select the most 
appropriate dissolution medium with a sink condition. 
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The solubility of CHD was determined by adding excess CHD to 3 mL of water or a 
PBS solution at pH 6.8. The samples were shaken at 37 ± 0.1 C for 24 hours. The 
suspensions were filtered through a 0.45µm Millipore membrane filter and the 
concentration of CHD was measured by UV detection at 254 nm (Biochrom WPA 
Biowave II UV- Spectrophotometry, UK). 
2.3  Particle size and morphological analyses 
The raw materials were assessed for their size. The volume-weighted particle size of 
Methocel, HPMC, P407 and CHD was assessed by laser diffraction using a Malvern 
Mastersizer 3000 with an Aero S dry dispersion unit system (Malvern Instruments, 
Malvern, UK). The cumulative particle sizes at 10, 50 and 90% were displayed as 
D0.1, D0.5 and D0.9, respectively. 
The morphology of the granules and the raw materials was assessed by scanning 
using electron microscopy (SEM), (Zeiss Evo® 50EP SEM, Germany). 
2.4  Preparation of tablets using the dry granulation technique 
The formulations of CHD mucoadhesive tablets were prepared as shown in Table 1. 
The powders were blended for 5 minutes in a V-shaped powder blender 
(CapsulCN®, China). Then, dry granules were prepared following the slugging 
method (Tuǧ cu-Demiröz et al., 2004) using a manual hydraulic hand press (diameter 
= 4 cm, weight = 5.5 ± 0.5 g). Slugs prepared using HPMC and Methocel were 
formed with a compression force of 10 and 40 KN, respectively. The slugs were 
crushed into granules and passed through a 1 mm screen (mesh no. 18). 
Magnesium stearate (0.5%) was added and mixed for 3 min prior to the compression 
of the granules into tablets. 
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Table 1 Formulations of CHD mucoadhesive buccal tablets. 
Formulations Weight (mg)/tablet 
CHD  
 
HPMC Methocel P407  Tablet 
Weight  
F1 
5 
25.0 - - 
30 
F2 20.5 - 4.5 
F3 17.5 - 7.5 
F4 11.5 - 13.5 
F5 6.25 - 18.75 
F6 - 25.0 - 
F7 - 20.5 4.5 
F8 - 17.5 7.5 
F9 - 11.5 13.5 
F10 - 6.25 18.75 
 
The tablets were pressed using a heavy duty mini rotary tablet machine (STC ZPS 
Shanghai, China) with a biconvex 6 mm diameter round shape punch. The average 
central thickness was 1.5 mm and the wall thickness (edge) was 1.0 mm.  
2.5  Flow properties and compressibility Index 
The bulk and the tapped volume of the powder blends and the granules were 
assessed using a tapped Density tester (Varian, UK). The tapped volumes were 
obtained by subjecting the powders to 200 taps each time until a constant volume 
was achieved. Carr’s Compressibility index (CI) was calculated using the flowing 
equation 
                       
Where V0 is bulk volume and Vt is the tapped volume. 
2.6 Characterisation of the buccal tablets 
2.6.1 Friability and tensile strength 
A sample of approximately 1 g of each formulation was evaluated for their friability 
using a friability tester (Charles Ischi AG, AE-1, UK), and rotated 100 times at 25 
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rpm. The mechanical strength of the biconvex tablet was calculated using the 
following equation (Pitt et al., 1988).  
         
                                     
 
Where    is the tensile strength, F is tablet hardness (Newtons), D is tablet diameter, H is tablet 
thickness, and W is central cylinder thickness (tablet wall height), with all tablet dimensions in mm.  
Tablet hardness was measured using a Varian VK 200, (UK) hardness tester (n = 
10). 
2.6.2 Ex-vivo mucoadhesion analysis  
The mucoadhesion was determined as a function of dosage form residence time 
using a modified protocol adopted from Nafee et al., (2003). Freshly harvested 
chicken crops were carefully washed to remove any residue of food the chicken had 
consumed, and they were subsequently stored at -80 C. The crops were defrosted 
before use, cut into small pieces (1 cm x 2 cm) and fixed to a glass slide using 
cyanoacrylate glue. The crop was hydrated using one drop of ultrapure water before 
a CHD tablet was placed on top and weighed down with a 4 g weight for 20 seconds 
to aid the adhesion process. The glass slide was then placed into the disintegration 
apparatus tubes (cylinders) (Varian VK 100, UK), prefilled with 37 ± 0.2C of 
ultrapure water (Figure 1). A test, similar to the disintegration test, was performed at 
50 rpm for 120 minutes with periodic sample examination for every 15 minutes to 
evaluate if the tablets had become detached from the chicken crops. The formulation 
of each tablet was performed in triplicate. 
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2.6.3 Swelling Index 
The swelling index was determined by weighing an individual CHD tablet (W0) and 
sticking it to a previously weighed glass coverslip using a single water droplet and 
allowing it to equilibrate for 30 seconds. The coverslip was then placed vertically in a 
beaker in a 37 ± 0.2 C water bath (Clifton, Nickel-Electro Ltd, UK). The weight of the 
swollen tablet (Ws) was recorded at 30, 60, 90 and 120 minutes. The swelling index 
(SI) was calculated using the following equation (Kassem et al., 2014). 
              
2.6.4 Tablet morphology (SEM) 
The morphology of aqueous media swollen tablets was investigated. They were 
prepared by adding 0.5 mL distilled water to each tablet in a 5 ml test tube and left 
until swollen. They were then freeze-dried using a Beta 1-8 LSC Freeze Dryer 
(Christ, UK). The tablets were cut in half and analysed using SEM as previously 
described. The surface area of the pores was measured using ImageJ 1.51n 
software. 
Figure 1 Ex-vivo mucoadhesion using the 
disintegration apparatus. 
  
 
  9 
 
2.6.4.1 Comparison of dissolution rate 
Similarity and difference factors were applied to compare the dissolution profiles of 
both groups of formulations. The similarity factor (f2) was calculated using the 
equation below. The results fell between 0-100%, and an f2 of ≥ 50 suggests a 
similarity between the standard and the test (Costa and Lobo, 2001).  
                          
 
 
   
 
    
      
Where n is the number of time points, Rt is the percent release of the standard and Tt is the 
percent release of the test. 
The difference factor (f1) was calculated using the equation below. Values of 
between 0-15 indicate that the difference between the samples is acceptable. When 
f1 = 0, the two samples are considered identical (Costa and Lobo, 2001). 
           
 
   
            
 
   
       
2.6.5 In-vitro dissolution of CHD (Apparatus I) 
The dissolution was performed using Varian 705 DS BP Dissolution Apparatus type I 
(basket method) (Varian, UK). One tablet of each formulation was placed in 500 ml 
of ultrapure distilled water at 37 ± 0.1 C, with the basket rotating at 50 ± 1 rpm. At 
predetermined time intervals, 4 ml was withdrawn from the dissolution medium and 
replaced with the same volume of fresh media. The CHD concentration was 
determined spectrophotometrically at 254 (Biochrom WPA Biowave II UV- 
Spectrophotometry, UK). 
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2.6.5.1 Kinetics of drug release  
The kinetics of CHD release were investigated to further understand the mechanism 
of CHD release and the effect of the different ratios of the polymers. Five models 
(Costa and Lobo, 2001) were used to analyse the release of CHD from the tablet 
matrices (Table 2). 
Table 2 Kinetic drug release models 
Model Equation 
Zero order          
First order                       
Higuchi        
    
Hixon-Crowell         
        
Korsmeyer-Peppas         
  
 
Where Q is the amount of drug released or dissolved at time t; Q0 is the amount of drug release or 
dissolved at time t (usually t = 0); Qt/Q is the fraction of drug released at time t; K is constant, and n 
indicates the release mechanism. 
 
2.7  Fourier Transform Infrared Spectroscopy (FTIR) and Differential Scanning 
Calorimetry (DSC) 
FTIR was used to investigate the possibility of interaction between the polymers and 
CHD. Spectra were obtained using a Bruker Alpha spectrometer (Germany) 
scanning and ranged from 4000 to 400 cm-1. 
DSC analysis was performed to investigate the interaction between CHD and the 
polymers during the processing steps.  Samples of 5.0 ± 0.2 mg each of CHD, 
HPMC, P407, F10 Physical mix, F10 granules and F10 tablet were investigated. 
  
 
  11 
 
Each was heated in an aluminium pan under a nitrogen flow of 40 mL/min from 25°C 
to 300°C at a scan rate of 10°C/min. The analysis was performed using Mettler 
Toledo DSC823e (Switzerland). 
3.   Results and discussion 
3.1 Solubility of CHD 
The solubility of CHD was investigated to determine the most appropriate dissolution 
medium to achieve sink condition. Its solubility in water and phosphate buffer saline 
(PBS) at pH 6.8 was 23.069 ± 1.928 and 0.047 ± 0.0124 mg/mL, respectively. The 
volume of the dissolution media should be at least 3-10 times that of the saturated 
volume (Rohrs, 2001). Simulated pH saliva using PBS did not achieve sink condition, 
which is an important criterion in dissolution. Water showed more than 10 times the 
saturated volume and was therefore selected as the dissolution medium.  
3.2 Particle size and morphology 
The particle sizes of CHD and their distribution and excipients are shown in Figure 2 
and Table 3. Both Methocel and HPMC have larger particles than CHD and P407, 
which is confirmed by the SEM micrographs (Figure 3). 
Table 3 Particle size distribution of CHD, Methocel F4M, HPMC and P407. 
 Raw material D 0.1 (µm) D 0.5 (µm) D 0.9 (µm) Span (µm) 
CHD 5.14 21.00 69.00 3.04 
HPMC  33.00 84.60 172.00 1.64 
Methocel 26.50 70.80 202.00 2.48 
P 407 11.50 34.50 74.30 1.82 
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Figure 2 Particle size distribution of CHD, Methocel F4M, HPMC and P407. 
The SEM micrographs (Figure 3) correspond with the laser diffraction results. Both 
CHD and P407 have smaller particle sizes and the latter tend to be more spherical. 
However, HPMC and Methocel possess larger particle sizes with irregular spherical 
and rod shapes, respectively.  
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Particle size analysis of Methocel showed a broadening of the distribution peak and 
a higher span value compared to HPMC (Figure 2) which can be attributed to the 
rod-like shape of the particles seen under SEM (Figure 3) (Naito et al., 1998). The 
particle size distribution of HPMC approximates to a nearly normal distribution 
pattern with SEM revealing more spherical or irregular spheres. 
3.3 Effect of particle morphology on tablet preparation 
The morphology of both the HPMC and Methocel samples (Figure 3) strongly 
influenced their flow behaviour’ HPMC displays a “passable” powder flow (CI of 
21.67), whereas Methocel has “poor” flow (CI of 33.33) (British Pharmacopoeia 
Comission, 2017). This finding was not unexpected as Hassan and Lau (2009) had 
reported the impeded flow of needle-shaped calcium carbonate particles (CI of 40) 
which resulted from inter-particulate interactions and aggregation. Moreover, the 
a b 
c d 
Figure 2 SEM images of (a) CHD (b) P407, (c) HPMC and (d) 
Methocel x500. 
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span value of Methocel is higher than HPMC which resulted in a decrease in the 
flowability. This confirms a previous finding by Liu et al., (2008), who found that the 
flowability is affected by both particle size and distribution. A particle size of below 
100 µm resulted in increased cohesiveness and decreased flowability (Table 3) (Liu 
et al., 2008), whereas a narrower distribution indicated better flowability. The various 
powder formulation blends were found not to be flowable (Table 4) and this may be 
due to the smaller mean particle size population of the formulations, resulting in a 
relatively high surface area and the potential for increased inter-particulate 
interactions which can decrease flowability. Dry granulation improved the flow 
properties of all formulation blends with most improving from ‘very, very poor’ to ‘very 
poor’, or from ‘very poor’ to ‘poor’ based on the British Pharmacopoeia.  
The applied force used to prepare the HPMC granules was 10 KN. In contrast, 
Methocel granules were initially prepared at 10 and 40 KN, but the 10 KN samples 
were rejected due to no improvement in flowability. This may be attributed to the rod-
like shape of Methocel particulates, which results in weak granules compact which is 
unable to maintain its shape. The flowability of granulated formulations of HPMC and 
Methocel prepared by both forces (10 or 40 KN) was similar. Increasing the P407 
content decreased the flowability of the powder blends, most likely because of the 
irregular shape, small particle size and cohesive properties of P407, which increases 
inter-particulate interactions and decreases packing efficiency as evidenced by a 
relatively high CI of 40 (Garg et al., 2018). Again, flow properties were improved after 
granulation, possibly as a result of the low melting point and the waxy nature of the 
P407, which may have decreased inter-particulate interactions and improved the 
packing efficiency. Granulated formulations with a high P407 ratio had a CI of 27. 
The SEM images confirmed that there was no great improvement in the flowability of 
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granules (Figure 4) due to the generation of fine particles when using dry granulation 
(Herting and Kleinebudde, 2007). 
 
Table 4 Compressibility index (CI%) for tablet blends before and after granulation. 
 
Formulations 
Powder Blends Granules 
CI% Flow Character CI% Flow Character 
F1 36.59 ± 4.00  Very poor 29.41 ± 1.03 poor 
F2 42.31 ± 1.61 Very, very poor 32.38 ± 1.58 Very poor 
F3 42.86 ± 1.55 Very, very poor 32.29 ± 1.47 Very poor 
F4 31.43 ± 2.91 Very poor 62.33 ± 0.00  poor 
F5 34.21 ± 3.62 Very poor 27.92 ± 0.92 poor 
F6 43.74 ± 1.32 Very, very poor 34.92 ± 1.37 Very poor 
F7 39.28 ± 2.24 Very, very poor 34.85 ± 0.00 Very poor 
F8 41.36 ± 2.12 Very, very poor 30.33 ± 3.21 poor 
F9 38.45± 4.43 Very, very poor 27.50 ± 0.87 poor 
F10 42.36 ± 5.81 Very, very poor 26.83 ± 0.76 poor 
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 Figure 4 SEM images of selected granules of HPMC and Methocel formulations, 
x200.
F3 
F1 F6 
F8 
F9 
F10 F5 
F4 
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3.3 Tensile strength and friability 
All the tablets showed a tensile strength of less than 1 MP, with Methocel 
formulations showing relatively higher tensile strengths than HPMC formulations. 
This might be due to the higher force used in the granulation for the former.  All had 
acceptable levels of friability of less than 1% (Table 5).  
Table 5 Tensile strength (n = 10) and friability (1g) of CHD tablets. 
 
 
 
 
 
 
 
 
 
 
3.4 Ex-vivo mucoadhesion  
Tablets were prepared with a convex surface. The advantage of this type of surface 
is that it prevents the tablet from dislodging due to movement of the mouth and 
reduces contact with the tongue and the teeth (Maurya et al., 2010). It makes the 
tablet less brittle during manufacturing and handling. Furthermore, upon application, 
it promotes rapid hydration around the perimeter and facilitates adhesion (Foreman 
et al., 2006). 
 All tablets successfully adhered to the chicken crop when repeatedly immersed, 
using the disintegration tester, in the aqueous medium for two hours, which 
corresponds to the selected residence time for CHD release from the tablets in the 
buccal cavity. This successful mucoadhesion may be due to the chain entanglement 
Formulations 
Tensile 
strength 
(MPa) 
Friability 
(%) 
F1  0.57 ± 0.19 0.48 
F2 0.49 ± 0.19 0.28 
F3 0.51 ± 0.14 0.12 
F4 0.73 ± 0.21 0.09 
F5 0.62 ± 0.15 0.36 
F6 0.78 ± 0.14 0.04 
F7 0.78 ± 0.18 0.02 
F8 0.66 ± 0.21 0.01 
F9 0.74 ± 0.28 0.06 
F10 0.88 ± 0.20 0.25 
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and physical interlinking interaction of both the Hydroxypropyl methylcellulose 
polymers and the P407 with the chicken crop mucous membrane. Neither polymer is 
capable of interacting with the mucin component of mucous as they are both 
uncharged (Sosnik et al., 2014). 
 
3.5 Swelling index (SI) and tablet morphology 
The swelling index for both Methocel and HPMC formulations (Figure 5, 
supplemental data) increased with time. Statistical analysis (two-way ANOVA with 
replication) revealed no statistical significance (p>0.05) between HMPC and 
Methocel formulations (F1 and F6). This indicates that the morphology of HPMC and 
Methocel particles does not have any impact on the swelling index. However, there 
was a significant difference for each group of formulations (p<0.001) for HPMC (F1 
and F5) and Methocel (F6 – F10).  
 
Figure 5 swelling index of CHD tablets (a) HPMC formulations and (b) Methocel 
formulations in ultrapure water and at 37 °C, Data are expressed as mean ± SD, n = 
3. 
 
Increasing P407 led to a significant decrease in the swelling index (p<0.001), for 
both HPMC formulations.  Upon hydration, the mobility of the macromolecules in 
Methocel and HPMC increases along with the rate of water movement (Siepmann 
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and Peppas, 2012). Moreover, hydrated P407 arranges itself into micellar structures 
that subsequently adopt a cubic shape once the hydrogel is formed. Intriguingly, the 
presence of HPMC in some of these formulations might facilitate the formation of a 
network of interconnected P407 micelles (Koffi et al., 2006).  
SEM micrographs of swollen tablets (Figure 6) show a sponge-like, porous network 
with a strong relationship between the shape of the pores and the morphology of the 
particles in Methocel and HPMC polymers (Figure 3) and their ratios in the 
formulations. F1 and F2 show smaller and more spherical pores compared to F6, F7 
and F8 which have elongated, larger pores. The effect is prominent when the ratio is 
greater than 50% in the tablet. For instance, the average cross-sectional surface 
area of the pores in F1 and F6 was 0.46±0.86 and 1.86±2.95 µm2, respectively. 
Although the average size of pores in F5 is ~4 times that of F1, the total surface area 
of the pores was 0.203 mm2 for the former and 0.234 mm2 for the latter, with a ratio 
of 0.9. This indicates that although the size and the morphology of the pores are 
different, the total surface area is not greatly affected by the morphology of the 
polymeric particles. Increasing P407 leads to the formation of irregular pores, 
possibly because of its surfactant properties which increase the solubility of other 
polymers and distorts their shapes. Another possibility is that it might be affected by 
the thermosensitive properties of P407, which melts at a low temperature, meaning 
that pore damage may occur during the freeze-drying process or during the sample 
cutting of freeze-dried tablets.  
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Figure 3 SEM micrographs of cross-section of freeze-dried swollen 
tablets. 
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3.6 In-vitro dissolution of CHD and data analysis 
The cumulative CHD release from both groups of tablets was affected by the ratio of 
P407. Increasing P407 content elevates drug release by as much as 30% for HPMC 
formulations (F1 to F5). For example, 60.53% of CHD was released from F1 
compared to 94.27% of CHD which was released from F5. Moreover, the cumulative 
CHD release from Methocel formulations F6 and F10 with the same composition as 
F1 and F5 were 57.77% and 94.58%, respectively. The increase in drug release was 
attributed to the solubilising activity of P407 (Figure 7). The copolymer P407 is a 
surfactant which is widely used to improve the aqueous solubility of poorly soluble 
drugs (Dumortier et al., 2006), and can also form a hydrogel at body temperature. 
However, the morphology of the particles of Methocel and HPMC did not affect CHD 
release, which might be explained by the equivalent cross-sectional surface area of 
pores in F1 and F6. Moreover, both formulations are similar in terms of cumulative 
drug release based on similarity factor (f2) and difference factor (f1), with values of 
81.1% and 6.87, respectively. F1 and F6 showed a cumulative release after two 
hours of 60.7% and 57.7%, while F5 and F10 showed 93.0% and 94.6%, 
respectively. Both F5 and F10 can be considered similar with a f2 of 77.68% and a  f1 
of 6.36. 
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Figure 7 Cumulative percentage release of CHD from (a) HPMC formulations and (b) 
Methocel formulations in ultrapure water at 37 ± 0.1 °C and 50 rpm, n = 3 ± SD. 
Although different compression forces of 10 KN for HPMC formulations and 40 KN 
for Methocel formulations were used to prepare the granules, this should not affect 
drug release. Velasco et al., (1999) reported that compression force has a minimal 
effect on drug release or the kinetics of release but can influence initial matrix 
porosity (before hydration). 
The kinetics of CHD release was investigated by fitting the release data to the 
following models: zero order, first order, Higuchi, Hixson-Crowell and Korsmeyer-
Peppas models (Table 2). Using the correlation coefficient (R2) values, the tablets 
fitted most closely with the Korsmeyer-Peppas kinetic model and the exponent n was 
found to be 0.45<n<0.89. This indicates that drug release is anomalous from 
cylindrical tablet (0.45 representing diffusional control and 0.89 indicating case-II 
transport which corresponds to zero order kinetic). Thus, CHD release is anomalous 
(Siepmann and Peppas, 2012). This leads to the conclusion that neither the 
morphology of polymer particles nor the ratio of P407 had an effect on the 
mechanism of drug release. 
Table 7 CHD release kinetics using different models. 
 Zero Order (R
2
) First order(R
2
) Higuchi (R
2
) Hixon Crowel (R
2
) K-Peppas (R
2
) K-Peppas (n) 
F1 0.9702 ± 0.0227 0.9826 ± 0.0149 0.9723 ± 0.0262 0.9697 ± 0.0285 0.9979 ± 0.0010 0.717 ± 0.139 
F2 0.9795 ± 0.0143 0.9825 ± 0.0078 0.9655 ± 0.0244 0.9757 ± 0.0188 0.9967 ± 0.0023 0.747 ± 0.137 
0 
20 
40 
60 
80 
100 
0  3 0  6 0  9 0  1 2 0  
C
h
lo
rh
ex
id
in
e 
P
er
ce
n
t R
el
ea
se
  
Time (min) 
a 
F1 F2 F3 F4 F5 
0 
20 
40 
60 
80 
100 
0 30 60 90 120 
C
h
lo
rh
ex
id
in
e 
P
er
ce
n
t R
el
ea
se
  
Time (min) 
b 
F6 F7 F8 F9 F10 
  
 
  23 
F3 0.9329 ± 0.0378 0.8943 ± 0.0843 0.9818 ± 0.0063 0.8567 ± 0.1076 0.9872 ± 0.0029 0.541 ± 0.105 
F4 0.9776 ± 0.0028 0.9867 ± 0.0078 0.9773 ± 0.0031 0.9777 ± 0.0130 0.9985 ± 0.0008 0.686 ± 0.027 
F5 0.9850 ± 0.0048 0.9806 ± 0.0035 0.9648 ± 0.0050 0.9940 ± 0.0014 0.9984 ± 0.0012 0.764 ± 0.029 
F6 0.9712 ± 0.0054 0.9833 ± 0.0067 0.9736 ± 0.0063 0.9483 ± 0.0128 0.9965 ± 0.0007 0.698 ± 0.033 
F7 0.9663 ± 0.0025 0.9854 ± 0.0028 0.9796 ± 0.0019 0.9714 ± 0.0042 0.9959 ± 0.0005 0.671 ± 0.018 
F8 09791 ± 0.0107 0.9972 ± 0.0010 0.9606 ± 0.0071 0.9942 ± 0.0030 0.9983 ± 0.0015 0.796 ± 0.009 
F9 0.9727 ± 0.0117 0.9952 ± 0.0012 0.9703 ± 0.0105 0.9894 ± 0.0081 0.9981 ± 0.0015 0.740 ± 0.044 
F10 0.9907 ± 0.0079 0.9700 ± 0.0143 0.9475 ± 0.0190 0.9872 ± 0.0059 0.9987 ± 0.0005 0.870 ± 0.113 
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3.7 Drug polymer interaction (FTIR and DSC) 
The FTIR spectra revealed that HPMC and Methocel are identical in terms of 
chemical composition. Moreover, analyses were performed (Figure 8) to evaluate 
possible interactions during the granulation and tableting process which might have 
resulted from the low melting point of P407. CHD displayed peaks at 3325  and 3119 
cm-1 (asymmetric and symmetric NH stretching vibrations), 2938 and 2886 cm-1 
(asymmetric and symmetric CH stretching), 1624 cm−1 (CN stretching vibration of 
imine group), 1522,1483 cm−1 (NH bending vibration of secondary amine and imine 
groups), 1406 cm−1 (C=C stretching vibrations of aromatic rings), 1290 and 1245 cm-
1CN stretching,   819 cm−1 (out of plane vibration of the aromatic ring  and the CCl) 
group’s spectra at 713 cm-1 (Holešová et al., 6014, and Yang et al., 2007). The 
characteristic peaks of HPMC are at 3445 cm-1 (OH stretching) and 2897 cm-1 (CH 
stretching), 1375 cm-1 (asymmetric CH3 bending vibration), 1049 cm
-1 (C-O 
asymmetric stretching vibration) and 942 cm-1 (C-O symmetric stretching vibration 
(Ding et al., 2015). P407  is characterised by principal peaks at 2875 cm–1 (CH 
stretching), 1346 cm-1 (OH bending) and 1094 cm–1 (CO stretching) (Vyas et al., 
2009). The analyses of tablet formulations (Figure 8 a and c) reveal that increasing 
the concentration of P407 leads to a decreased intensity of CHD and the 
disappearance of hydrogen bonding peaks at 3325 and 3119 cm-1. This is prominent 
in F5 and F10. In contrast, F1, F2, F6 and F7 show a combination of the peaks of all 
ingredients. The concentration-dependent interaction between CHD and P407 is 
attributed to the steric hindrance properties of P407, resulting in the shielding of CHD 
(Göppert and Müller, 2005). The peaks of HPMC overlap with those of P407, with 
the CO stretching of HPMC, Methocel and P407 combining into one peak at around 
1097 cm-1 in F2, F8 and F5 and F8-F10. However, in F1 and F6, this peak shifts to 
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1049 cm-1. Further investigation was performed to analyse  F5 and F10, the physical 
mix, the granules and the tablets (Figure 8 b and d). All FTIR spectra have identical 
peaks, meaning that during the mixing process of the excipient, hydrophobic 
interactions occur between  CHD and P407 ending in steric hindrance by the latter. 
Although this interaction is more common in liquid formulations, in the current 
formulation the interaction is aggravated by the small particle size of both CHD and 
P407.  
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Figure 8 FTIR spectra of a) HPMC formulations b) F5 physical mix (PM), granules (Gran) and tablet (Tab), c) 
Methocel formulations and d) F10 PM, Gran and Tab. 
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Figure 9 shows the DSC thermograms for raw materials, the physical mixture, the 
granules and the tablet of F10 formulation, which has the highest drug release. CHD 
has two melting peaks at 158 and 176ºC, which indicates its polymorphic nature. 
Methocel reflects its amorphous nature while P407 has a melting peak at 57ºC. The 
F10 physical mix, the granules and the tablet thermograms showed that the 
endothermic peak of poloxamer occurred at around the same temperature. The first 
melting peak of CHD was shifted to 156ºC in the physical mix and to 153ºC in the 
granules and the compressed tablet. The small melting peak disappeared in the 
physical mix and granules but in the tablet, it shifted to 173ºC. The shifting and the 
disappearance of the melting peaks in the physical mix and the granules indicate 
there is an interaction between the chlorhexidine and the P407. However, the re-
appearance of the second endothermic peak in the tablet is attributed to phase 
separation resulting from tablet compression (Singh et al., 2016).  
  
28 
 
0 50 100 150 200
E
x
o
th
e
rm
ic
Time (min)
 Tab F10
 Gran F10
 PM F10
 P407
 Methocel
 CHD
 
Figure 9 DSC thermograms of F10 physical mix (PM), Granules (GRAN), tablet 
(TAB), CHD, Methocel and P407. 
 
The interaction between the excipients and CHD were tested using FTIR and DSC. 
The FTIR spectra revealed that increases in the ratio of P407 led to a decrease in 
the intensity of CHD which can be attributed to steric hindrance by P407. The FTIR 
spectra for the F5 physical mix, the granules and the tablet showed identical spectra 
with that of the F10. This indicates that no interaction occurred during the process of 
tableting and the sources of the polymer showed no differences in behaviour. 
Moreover, DSC analysis was performed on the F10 formulation only and showed no 
interactions between the drug and the polymers in the prepared table. 
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3.8 Conclusions 
CHD buccal tablets were successfully prepared using two different sources of 
hydroxypropyl methylcellulose polymer. Both groups of formulations showed 
comparable drug release and kinetics of drug release. The addition of the 
thermosensitive hydrogel-forming polymer P407 to the formulations improved CHD 
release from the tablets without negatively impacting on the duration of 
mucoadhesion. In vivo work will be undertaken in the future to further investigate the 
safety and efficacy of the prepared buccal tablets for future application in the 
treatment of OPC.  
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